Skip to main content Skip to navigation
Purified Mouse Anti-Human HLA-DM
Purified Mouse Anti-Human HLA-DM
Profile of intracellular staining of peripheral blood lymphocytes analyzed on a FACScan (BDIS, San Jose, CA).
Purified Mouse Anti-Human HLA-DM
Profile of intracellular staining of peripheral blood monocytes analyzed on a FACScan (BDIS, San Jose, CA).
Profile of intracellular staining of peripheral blood lymphocytes analyzed on a FACScan (BDIS, San Jose, CA).
Profile of intracellular staining of peripheral blood monocytes analyzed on a FACScan (BDIS, San Jose, CA).
製品詳細
Down Arrow Up Arrow


BD Pharmingen™
Human (QC Testing)
Mouse IgG1, κ
Intracellular staining (flow cytometry) (Routinely Tested)
0.5 mg/ml
AB_396271
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
555982 Rev. 5
抗体の詳細
Down Arrow Up Arrow
MaP.DM1

Reacts with human leukocyte antigen-DM (HLA-DM), a non-classical MHC class II molecule expressed in the cytoplasm of antigen presenting cells (APC). HLA-DM is composed of alpha and beta subunits which form a similar structure as the classical class II molecules. HLA-DM catalyzes the dissociation of CLIP from MHC class II-CLIP complexes in vitro and facilitates the binding of antigenic peptides. It also prevents self-antigens from becoming stably complexed with class II molecules and being presented to T cells.

555982 Rev. 5
フォーマットの詳細
Down Arrow Up Arrow
Purified
Tissue culture supernatant is purified by either protein A/G or affinity purification methods. Both methods yield antibody in solution that is free of most other soluble proteins, lipids, etc. This format provides pure antibody that is suitable for a number of downstream applications including: secondary labeling for flow cytometry or microscopy, ELISA, Western blot, etc.
Purified
555982 Rev.5
引用&参考文献
Down Arrow Up Arrow

Development References (6)

  1. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 1995; 82(1):155-165. (Biology). View Reference
  2. Denzin LK, Hammond C, Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med. 1996; 184(186):2153-2165. (Biology). View Reference
  3. Denzin LK, Robbins NF, Carboy-Newcomb C, Cresswell P. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity. 1994; 1(7):595-606. (Biology). View Reference
  4. Kropshofer H, Hämmerling GJ, Vogt AB. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest. Immunol Today. 1997; 18(2):77-82. (Biology). View Reference
  5. Riberdy JM, Avva RR, Geuze HJ, Cresswell P. Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines. J Cell Biol. 1994; 125(126):1225-1237. (Biology). View Reference
  6. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 1992; 360(6403):474-477. (Biology). View Reference
すべて表示する (6) 表示項目を減らす
555982 Rev. 5

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.